Events
2023 Toronto Prostate Cancer Genetics Retreat
| Session 1: Targeted Therapies
Moderator: Dr. Chris Wallis |
| Management of Advanced Prostate Cancer: A New Era
Dr. Maria Jiang, Genitourinary Medical Oncologist, UHN |
| Molecular landscape of high-risk localized prostate cancer in the Genomic Umbrella Neoadjuvant Study (GUNS)
Dr. Joshua Scurll, Prostate Centre, University of British Columbia |
| Session 2: Health and Genetic Services
Moderator: Emily Thain |
| Barriers to Germline Testing in Prostate Cancer in the US
Dr. Benjamin Davies, Professor of Urology, Pittsburgh University |
| Genetic Counselling for Prostate Cancer
Mr. Justin Lorentz, Genetic Counsellor, Sunnybrook Health Sciences |
| A Patient Experience
Robert Kamen, Toronto |
| Session 3: Molecular Genetics and Heritable Risk
Moderator: Dr. Mohammad Akbari |
| Recent Developments in Prostate Cancer Polygenic Risk Scores (PRS)
Dr. Burcu Darst, Genetic Epidemiologist, Fred Hutchinson Cancer Research Center |
| Universal Testing in Oncology
Dr. Raymond Kim, Medical Director of Cancer Early Detection, PMH |
| The Canadian Uptake of Genetic Testing in Prostate Cancer
Julie Reynolds, Senior Manager Diagnostics – Oncology, AstraZeneca |
| Session 4: Global Innovation and Industry Perspectives
Moderator: Dr. Roderick Clark |
| Addressing Disparities in Genetic Testing in the Era of PARP Inhibitors for Prostate Cancer
Sasha Farina, Field Medical Advisor – Oncology, Pfizer |
| Real World Landscape of Genomic Testing in Canada
Katherine Chan, Medical Science Liaison, Janssen Canada Inc. |
| Session 5: Translational Research and the Future of Genomics
Moderator: Dr. Rashid Sayyid |
| Hereditary Cancer Surveillance Using Cell-free DNA Sequencing
Dr. Trevor Pugh, Canada Research Chair in Translational Genomics; Senior Scientist, Princess Margaret Cancer Centre; Director of Genomics, OICR; Associate Professor, Department of Medical Biophysics, University of Toronto. |
| Prostate Cancer: from germline context to somatic evolution to clinical aggression
Dr. Paul C. Boutros, Professor of Human Genetics and Urology at the David Geffen School of Medicine, UCLA |
| Horizon Scanning in Prostate Cancer Therapeutics
Dr. Anthony Joshua, Head of Department of Medical Oncology, Kinghorn Cancer Centre; Chair, Australian Ocular Melanoma Alliance c/o MASC Trials; Staff Specialist, St Vincent’s Hospital, Sydney |